Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.

Topline data from both Phase 3 trials is expected in the second quarter of 2026, with NDA submission to follow thereafter.

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Oculis Holding has concluded subject enrolment for the Phase III DIAMOND-1 and DIAMOND-2 clinical trials of OCS-01 eye drops ...

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

The bloodbath in Wall Street looks set to extend into the new week, says Yeap Jun Rong, market strategist at trading ...

Nearly every family issue is fully unpacked in Purpose, Branden Jacobs-Jenkins’ exceptional drama that makes its Broadway ...

Project Community Connect returns to Missoula Public Library, offering free services to our neighbors in need on April 11, ...

Medically reviewed by Christine L. Larsen, MD Glassy eyes occur when your eyes appear glazed over or shiny, like glass.

They block a chemical that causes inflammation. They can be given in a few different forms. Eye drops. If your uveitis is at the front of your eye and isn't caused by an infection, steroid drops ...

“Taking a warm shower helps drop your core body temperature ... Sleep spray, earphones and an eye mask = the perfect sleep combo. Picture: news.com.au Having this hard cut-off time was important ...

Fortnite offers exclusive in-game cosmetics via Twitch Drops from March 28 to April 8, 2025. Players can earn items like the Command Executor Pickaxe and Lil’ Armored Truck Emote by watching ...